Compare TPB & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TPB | PLSE |
|---|---|---|
| Founded | 1988 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Tobacco | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.8B |
| IPO Year | 2015 | 2015 |
| Metric | TPB | PLSE |
|---|---|---|
| Price | $81.31 | $25.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $115.00 | $22.00 |
| AVG Volume (30 Days) | ★ 401.8K | 265.5K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.39% | N/A |
| EPS Growth | ★ 45.33 | N/A |
| EPS | ★ 3.11 | N/A |
| Revenue | ★ $463,062,000.00 | N/A |
| Revenue This Year | $13.68 | $840.00 |
| Revenue Next Year | $11.32 | $287.54 |
| P/E Ratio | $25.56 | ★ N/A |
| Revenue Growth | ★ 28.39 | N/A |
| 52 Week Low | $65.80 | $12.56 |
| 52 Week High | $146.90 | $28.53 |
| Indicator | TPB | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 43.43 | 53.19 |
| Support Level | $66.94 | $23.60 |
| Resistance Level | $84.94 | $27.60 |
| Average True Range (ATR) | 3.70 | 1.85 |
| MACD | -0.50 | -0.14 |
| Stochastic Oscillator | 24.56 | 39.25 |
Turning Point Brands Inc operates as a manufacturer, marketer, and provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum, including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments, namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.